BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 32 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $364,000 | +22.6% | 295,007 | -16.3% | 0.00% | 0.0% |
| Q1 2020 | $297,000 | -98.8% | 352,415 | -98.8% | 0.00% | -98.9% |
| Q4 2019 | $24,085,000 | +0.5% | 28,500,000 | -23.0% | 0.09% | -1.1% |
| Q3 2019 | $23,956,000 | – | 37,000,000 | -51.3% | 0.09% | – |
| Q2 2019 | $0 | – | 76,000,000 | +198.0% | 0.00% | – |
| Q1 2019 | $0 | – | 25,500,000 | +12.3% | 0.00% | – |
| Q4 2018 | $0 | – | 22,708,000 | +4326.5% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 513,000 | -0.8% | 0.00% | -100.0% |
| Q2 2017 | $615,000 | -66.5% | 517,000 | -66.7% | 0.00% | -60.0% |
| Q1 2017 | $1,834,000 | +1379.0% | 1,553,000 | +1569.9% | 0.01% | – |
| Q4 2015 | $124,000 | -98.4% | 93,000 | -98.1% | 0.00% | -100.0% |
| Q2 2015 | $7,947,000 | +7190.8% | 4,990,000 | +6830.6% | 0.02% | – |
| Q1 2015 | $109,000 | – | 72,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|